Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on PAY, RPRX, RBCN and SFY Issued by the Bedford Report

RPRX, RBCN, PAY
Free Research Reports on PAY, RPRX, RBCN and SFY Issued by the Bedford Report
http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=989027&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwire) -- 02/22/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

VeriFone Systems Inc. (NYSE: PAY) shares plunged 42.8 percent on more than 50 million shares traded Thursday to close at $18.24 a share. The company has lowered its forecasts for the first fiscal quarter of 2013 due to "continued weak macro-economic conditions in Europe."

Find out more about VeriFone Systems including full access to the free equity report at: www.BedfordReport.com/PAY

Repros Therapeutics Inc. (NASDAQ: RPRX) shares soared 24.6 percent on 5.18 million shares traded Thursday, which was nearly six times the average daily volume. The company announced that the FDA has informed the company to continue the study of their male testosterone drug, ZA-301, as planned.

Find out more about Repros Therapeutics including full access to the free equity report at: www.BedfordReport.com/RPRX

Rubicon Technology, Inc. (NASDAQ: RBCN) shares declined 14.73 percent on more than three times the average daily volume Thursday to close at $4.92 a share. The company reported a loss per share of $0.05 in the fourth quarter compared to a diluted EPS of $0.01 in the third quarter of 2012.

Find out more about Rubicon Technology including full access to the free equity report at: www.BedfordReport.com/RBCN

Swift Energy Company (NYSE: SFY) shares fell 4.95 percent on over 4 million shares traded Thursday, which was over six times the average daily volume. The company reported earnings from continuing operations of $11.2 million in the fourth quarter, a 46 percent decline when compared to the $20.7 million posted in the fourth quarter of 2011.

Find out more about Swift Energy including full access to the free equity report at: www.BedfordReport.com/SFY

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today